Coxiella burnetii


Atypical Organisms
>Chlamydophila pneumoniae
>Chlamydophila psittaci
>Coxiella burnetii led
>Legionella species ( L. pneumophila)
>Mycoplasma pneumonia

>Coxiella burnetii led
>Ehrlichia species, Anaplasma
     1] Anaplasma phagocytophilum (Ehrlichia phagocytophilum)
     2] Ehrlichia chaffeensis
     3] Ehrlichia ewingii
     4] Ehrlichia ewubguum
Coxiella burnetii

  • -obligate intracellular bacterial pathogen.
  • -morphologically similar to Rickettsia.
  • -causative agent of Q fever.
  • -small Gram-negative bacterium that is highly resistant to environmental stresses such as high temperature, osmotic pressure, and ultraviolet light.
  • -C. burnetii one of the most infectious known organisms  (infectious dose only 1-10 organisms).
  • -Disease occurs in two stages: an acute stage that presents with headaches, chills, and respiratory symptoms, and an insidious chronic stage.

top of page


Important considerations:  The choice of an agent should be based on local antimicrobial sensitivities, site of infection, cost, and comorbid conditions.   Generally, the most common agents/regimens are listed first.   Listed dosages may need to be adjusted for renal dysfunction. 

  1. Doxycycline 100mg orally twice daily [Range: 100-200mg in 1-2 divided doses]
  2. Bactrim DS (TMP-SMX) 160/800mg po bid
  3. Doxycycline 100mg orally twice daily + hydroxychloroquine
  4. Ciprofloxacin 500-750 mg orally q12h or 200-400mg IV q12h
  5. Moxifloxacin 400mg orally/IV qd
  6. Azithromycin
  7. Clarithromycin 500mg po q12h 
  8. Chloramphenicol 50-100 mg/kg/day in divided doses every 6 hours (Maximum daily dose is 4 grams e.g. 1 gram q6h)


The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer